company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,211312000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,12382000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,17269000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,241113000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,9286000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,21023000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30309000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,,totalassets,Total Assets,=,debit,usd,271531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,205371000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,177000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,60216000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3213000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,28053000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2364000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4161000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,4042000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,307597000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,388092000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,10700000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,398792000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,706389000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-194785000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-257153000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17080000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-434858000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-434858000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-434858000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q2,,2010-06-30,2010-07-29 15:12:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,271531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,200486000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26704000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,250000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7868000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,235308000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,94000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,16922000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5183000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22105000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,,totalassets,Total Assets,=,debit,usd,257507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,112423000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1288000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21794000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,70199000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3213000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,298000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,209215000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,340608000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,12226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,352834000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,562049000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-88921000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-216964000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1343000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-304542000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-304542000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-304542000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2010.0,Q3,,2010-09-30,2010-11-09 16:07:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,257507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,126713000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33685000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,17057000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7787000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,185392000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,65000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,33065000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,24595000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5587000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,63247000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,,totalassets,Total Assets,=,debit,usd,248704000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,251141000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,286000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30956000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,62862000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1713000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,346958000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,243419000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,29531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,272950000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,619908000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-169735000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-196879000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4590000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-371204000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-371204000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-371204000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q1,,2011-03-31,2011-04-28 14:35:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,248704000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,168022000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,30269000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3698000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,10442000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,212431000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,51000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,38030000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,24861000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8888000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,71779000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,,totalassets,Total Assets,=,debit,usd,284261000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,123246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,124000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,33134000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,dividendspayable,Dividends Payable,+,credit,usd,41961000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1713000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,12575000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4270000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,217023000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,332596000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,28149000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,360745000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,577768000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-160618000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-126893000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5996000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-293507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-293507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-293507000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q2,,2011-06-30,2011-07-29 17:06:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,284261000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,157132000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37847000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9677000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,13540000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,218196000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,36000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,30356000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,14033000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7904000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,52293000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,,totalassets,Total Assets,=,debit,usd,270525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,115268000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,272000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,58028000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,173568000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,315368000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,24828000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,340196000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,513764000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-160492000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-80977000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1770000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-243239000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-243239000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-243239000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2011.0,Q3,,2011-09-30,2011-11-09 16:30:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,270525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,141368000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,46010000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8073000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,10749000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,206200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,27000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5134000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,7426000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,6646000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9530000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28736000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,,totalassets,Total Assets,=,debit,usd,234963000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,69531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,471000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,79639000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,149641000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,302241000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,26861000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,329102000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,478743000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-233396000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1851000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-8533000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-243780000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-243780000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-243780000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q1,,2012-03-31,2012-05-03 16:05:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,234963000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,184506000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,43812000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3340000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,5162000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,236820000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,33000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1015000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,7435000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4848000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9678000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22976000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,,totalassets,Total Assets,=,debit,usd,259829000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,22738000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,155000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,51006000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,18588000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,92487000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,304767000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,23689000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,328456000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,420943000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-233166000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,71651000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,401000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-161114000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-161114000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-161114000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q2,,2012-06-30,2012-08-02 16:11:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,259829000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,132590000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,20000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,27777000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,13182000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5775000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3552000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,202876000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,33490000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,6162000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7338000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46990000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,,totalassets,Total Assets,=,debit,usd,249896000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31483000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32296000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,307337000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25747000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,333084000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,365380000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-232971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,120226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2739000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-115484000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-115484000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-115484000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2012.0,Q3,,2012-09-30,2012-11-05 16:11:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,249896000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,182192000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,20000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,5021000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,44682000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6427000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,235000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,258707000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,56000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,45502000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3614000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4931000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,54047000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,,totalassets,Total Assets,=,debit,usd,312810000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,504000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,68281000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,68785000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,312613000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25083000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,337696000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,406481000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-232512000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,139118000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-277000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-93671000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-93671000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-93671000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q1,,2013-03-31,2013-05-09 16:03:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,312810000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,251473000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,20000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,7377000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,40000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3630000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1437000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,283957000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,53000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,110593000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3296000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,117414000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,,totalassets,Total Assets,=,debit,usd,401424000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,169521000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,115000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,48837000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,18753000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,237226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,145799000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19660000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,165459000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,402685000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-232282000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,232834000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-1261000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-1261000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-1261000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q2,,2013-06-30,2013-08-08 16:02:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,401424000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,319596000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6862000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,900000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3180000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2416000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,332954000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,47000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,90815000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3835000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2021000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,96671000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,,totalassets,Total Assets,=,debit,usd,429672000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,171066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1469000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,33524000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3231000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,209290000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,147015000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,20480000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,167495000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,376785000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-232124000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,289060000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4049000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,52887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,52887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,52887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2013.0,Q3,,2013-09-30,2013-11-06 16:03:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,429672000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,334035000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,3558000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,1200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11650000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3104000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2053000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,355600000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,35000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,247200000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,223746000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,17369000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8629000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,496944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,,totalassets,Total Assets,=,debit,usd,852579000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,252196000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,410000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,87030000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,5335000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,344971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,270944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,34450000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,305394000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,650365000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-119409000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,326808000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5185000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,202214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,202214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,202214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q1,,2014-03-31,2014-05-12 16:04:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,852579000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,214525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,3243000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,6599000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1352000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1793000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2535000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,230047000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,69000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,413720000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,17395000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,255174000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,686289000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,,totalassets,Total Assets,=,debit,usd,916405000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,235321000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,341000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,61935000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,10817000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,308414000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,272824000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,38506000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,311330000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,619744000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-118987000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,418746000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3098000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,296661000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,296661000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,296661000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q2,,2014-06-30,2014-08-18 16:01:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,916405000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,281607000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2847000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,55289000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,250000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1446000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,341439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,72000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,363289000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,25096000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,249973000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,638358000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,,totalassets,Total Assets,=,debit,usd,979869000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,218389000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1079000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,35677000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,6494000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,261639000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,274512000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,41712000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,316224000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,577863000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-118577000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,520976000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-393000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,402006000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,402006000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,402006000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2014.0,Q3,,2014-09-30,2014-11-10 16:16:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,979869000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,416668000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2252000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,63439000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18308000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,500667000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,52000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,302367000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,34917000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,276130000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,613414000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,,totalassets,Total Assets,=,debit,usd,1114133000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,253985000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,615000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,81481000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,6667000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,342748000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,277975000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,41466000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,319441000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,662189000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-117751000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,561785000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7910000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,451944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,451944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,451944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q1,,2015-03-31,2015-05-06 16:02:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1114133000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,292065000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,2020000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,64797000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,400000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7815000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,367097000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,42000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,304910000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,35599000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,287893000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,628402000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,,totalassets,Total Assets,=,debit,usd,995541000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,74648000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,701000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,57951000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,10643000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,143943000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,279751000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,44633000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,324384000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,468327000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-117525000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,640024000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4715000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,527214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,527214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,527214000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q2,,2015-06-30,2015-08-05 16:08:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,995541000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,227855000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1827000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,67246000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,594000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9166000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,306688000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,42000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,286160000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,36499000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,391212000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,713871000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,,totalassets,Total Assets,=,debit,usd,1020601000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,49842000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,421000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32711000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,11615000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,94589000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,281581000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,48474000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,330055000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,424644000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-116904000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,709470000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3391000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,595957000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,595957000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,595957000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2015.0,Q3,,2015-09-30,2015-11-04 16:03:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1020601000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,290650000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1306000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,84615000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,607000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,377178000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,22000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,287241000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,26358000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,364576000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,678175000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,,totalassets,Total Assets,=,debit,usd,1055375000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,662000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7253000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,21019000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28934000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,230850000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,53060000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,283910000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,312844000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-115554000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,857667000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,418000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,742531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,742531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,742531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q1,,2016-03-31,2016-05-04 16:10:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1055375000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,115854000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,105938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,95359000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2881000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,673000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,320705000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,75000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,276823000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,25707000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,350938000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,728468000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,,totalassets,Total Assets,=,debit,usd,1049191000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1073000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11738000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,9793000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22604000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,232847000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,55088000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,287935000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,310539000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-114887000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,853539000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,738652000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,738652000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,738652000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q2,,2016-06-30,2016-08-04 16:10:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1049191000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,106590000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,7985000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,131123000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,31792000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,1593000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,973000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,75000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,355056000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,189874000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,3735000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,234556000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,24234000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,408595000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,860994000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,,totalassets,Total Assets,=,debit,usd,1216066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7134000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9479000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11608000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,5793000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,87500000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,121514000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,234895000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,105801000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,340696000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,462210000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-117813000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,867442000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,3000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,749632000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,749632000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,4224000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,753856000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2016.0,Q3,,2016-09-30,2016-11-03 17:23:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1216066000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,314327000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19991000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,103622000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21679000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3533000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5867000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,75000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,544019000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,846000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,157403000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,222527000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,11658000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,301320000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,692908000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,,totalassets,Total Assets,=,debit,usd,1237773000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,122692000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17956000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,36800000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,9309000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,88493000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,275250000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,112426000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,87161000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,199587000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,474837000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-112070000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,872078000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1305000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,758703000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,758703000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,4233000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,762936000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q1,,2017-03-31,2017-05-03 16:23:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1237773000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,349428000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,10895000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,62361000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20799000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11450000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6876000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,75000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,536809000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9012000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,154832000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,228349000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,21615000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,351354000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,756150000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,,totalassets,Total Assets,=,debit,usd,1301971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,123793000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10385000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,38108000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,15001000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,89000000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,276287000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,114044000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,92842000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,206886000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,483173000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-113720000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,932518000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,818798000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,818798000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,818798000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q2,,2017-06-30,2017-08-03 17:04:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1301971000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,510085000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6409000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,57545000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17465000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12216000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9510000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,613230000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8130000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,14491000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,222074000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,6186000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,359727000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,602478000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,,totalassets,Total Assets,=,debit,usd,1223838000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,124922000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10448000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,51607000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,7155000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,194132000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,115716000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,91008000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,206724000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,400856000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-101048000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,923382000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,822334000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,822982000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,822982000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2017.0,Q3,,2017-09-30,2017-11-13 17:05:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1223838000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,405078000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,55836000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,22646000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14012000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13372000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,510944000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7557000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,14975000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,213186000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2588000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,351151000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,581900000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,,totalassets,Total Assets,=,debit,usd,1100401000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9954000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40138000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,871000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50963000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,119166000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,87163000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,206329000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,257292000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-99958000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,944255000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1188000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,843109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,843109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,843109000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q1,,2018-03-31,2018-05-09 16:03:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1100401000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,395653000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,58058000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19531000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14801000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20628000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,508671000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9223000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,12829000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,54472000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,360800000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,428101000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,,totalassets,Total Assets,=,debit,usd,945995000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11212000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,34294000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,217000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,45723000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,120945000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,66699000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,187644000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,233367000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-98769000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,811397000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,712628000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,712628000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,712628000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q2,,2018-06-30,2018-08-09 16:31:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,945995000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,400984000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,60280000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15437000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,12515000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18533000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,507749000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8838000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,10686000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,52895000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,404259000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,467840000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,,totalassets,Total Assets,=,debit,usd,984427000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9011000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37570000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,91000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,46672000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,179168000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,19609000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,198777000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,245040000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-96180000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,835567000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,739387000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,739387000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,739387000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2018.0,Q3,,2018-09-30,2018-11-07 16:03:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,984427000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,366324000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,63056000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15739000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,15547000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16880000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,477546000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7110000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,648000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,49746000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,388483000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,438877000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,,totalassets,Total Assets,=,debit,usd,923533000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12430000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30867000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,21000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43318000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,186431000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,186431000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,229749000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-95631000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,790396000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1490000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,693275000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,693275000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,509000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,693784000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q1,,2019-03-31,2019-05-09 16:07:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,923533000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,284941000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,63280000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17872000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16263000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,17347000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,399703000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6914000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,547000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,50449000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,432848000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,483844000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,,totalassets,Total Assets,=,debit,usd,890461000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14812000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23499000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,25000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,38336000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,186701000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,186701000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,225037000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-93308000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,759080000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-546000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,665226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,665226000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,198000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,665424000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q2,,2019-06-30,2019-08-07 16:31:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,890461000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,294270000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,63317000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12581000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,20942000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15779000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,406889000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6576000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,691000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,47349000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,403640000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,451680000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,,totalassets,Total Assets,=,debit,usd,865145000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13256000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,27653000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,17000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,40926000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,186785000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1082000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,187867000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,227711000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,-99277000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,736695000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,637418000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,637418000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,16000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,637434000.0
PDL BioPharma Inc,PDLI,FE4K0NQFI4D86DSOL165,0000882104,2019.0,Q3,,2019-09-30,2019-11-06 16:14:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,865145000.0
